Furthermore, the in vitro sensitivity of HNSCC cell lines to anticancer agents, including EGFR inhibitors and cisplatin, has been shown to be influenced by the expression of EMT-associated genes [7], [8]. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.